Sector--
Established Date29/06/2022
Listing Date31/01/2025
ExchangeNASDAQ Stock Exchange
Full-time Employees82
Fiscal Year Ends31/12
Security TypeCommon stock
Office address3 World Trade Center, 175 Greenwich Street, New York, New York 10007
Business
IntroductionMetsera, Inc., was originally incorporated under the laws of the State of Delaware on June 29, 2022. The company is a clinical-stage biotechnology company developing next-generation injectable and oral trophic stimulating hormones, or NUSH, analog peptides, for the treatment of obesity, overweight and related diseases.
